Osaic Holdings’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
Other funds holding HCWB
Osaic Holdings's HCWB Position: Q3 2026 in Review
Osaic Holdings increased its HCW Biologics (HCWB) stake by 25% in Q3 2026, buying an estimated $3 and bringing the position to 5 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #8027.
Osaic Holdings first reported a position in HCWB in Q1 2025 and has held it in 7 quarters since. The position peaked at $285 in Q1 2025. 8 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.
- Osaic Holdings held 5 shares of HCW Biologics worth $9 as of Q3 2026.
- Osaic Holdings bought 1 HCW Biologics share in Q3 2026, an estimated $3.
- HCW Biologics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #8027 holding.
- Osaic Holdings first reported a position in HCW Biologics in Q1 2025 and has held it in 7 quarters since.
- Osaic Holdings's HCW Biologics position peaked at $285 in Q1 2025.
- 8 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.